The Role of Dexmedetomidine (Precedex®) - RT Journal On-Line
... safety and efficacy of dexmedetomidine in 30 patients who needed mechanical ventilation after surgery. A score between 60 and 70 was needed to achieve adequate sedation. If the target level was unattainable with the study drug alone, the patient was given additional boluses of propofol, followed by ...
... safety and efficacy of dexmedetomidine in 30 patients who needed mechanical ventilation after surgery. A score between 60 and 70 was needed to achieve adequate sedation. If the target level was unattainable with the study drug alone, the patient was given additional boluses of propofol, followed by ...
1 - UAMS Translational Research Institute
... and safety. This is particularly important for investigational agents, and may not be necessary for commercially available drugs, and/or drugs with sufficient clinical data. A summary from relevant clinical studies, with focus on those that provide background for your study. Please include importa ...
... and safety. This is particularly important for investigational agents, and may not be necessary for commercially available drugs, and/or drugs with sufficient clinical data. A summary from relevant clinical studies, with focus on those that provide background for your study. Please include importa ...
KADCYLA Product Monograph
... dyspnea, cough, fatigue, and pulmonary infiltrates. These events may or may not occur as part of an infusion-related reaction. It is recommended that treatment with KADCYLA be permanently discontinued in patients who are diagnosed with ILD or pneumonitis. Patients with dyspnea at rest due to complic ...
... dyspnea, cough, fatigue, and pulmonary infiltrates. These events may or may not occur as part of an infusion-related reaction. It is recommended that treatment with KADCYLA be permanently discontinued in patients who are diagnosed with ILD or pneumonitis. Patients with dyspnea at rest due to complic ...
Extract from Clinical Evaluation Report
... demonstrated in-vitro pharmacologic activity similar to unchanged regorafenib. Therefore evaluation of the two metabolites is included in the PK studies. Following oral administration of single doses of 160mg tablets to cancer patients regorafenib is absorbed relatively rapidly with a median Tmax ra ...
... demonstrated in-vitro pharmacologic activity similar to unchanged regorafenib. Therefore evaluation of the two metabolites is included in the PK studies. Following oral administration of single doses of 160mg tablets to cancer patients regorafenib is absorbed relatively rapidly with a median Tmax ra ...
Spinal Cord Injury
... influence on the ADL, mobility and possibility of independence of the patient. Community accessibility Community accessibility gives information about the way the patient moves from one place to another (car, bike, etc.) and what efforts this takes. Psychological status Psychological status is the p ...
... influence on the ADL, mobility and possibility of independence of the patient. Community accessibility Community accessibility gives information about the way the patient moves from one place to another (car, bike, etc.) and what efforts this takes. Psychological status Psychological status is the p ...
Worldwide Aeromedical Evacuation
... ground transportation, feeding and limited medical care for patients entering, en route in, or leaving an aeromedical evacuation system. A Mobile Aeromedical Staging Facility (MASF) is used in tactical aeromedical evacuation. Although function is the same as any ASF, it is comprised of tentage, equi ...
... ground transportation, feeding and limited medical care for patients entering, en route in, or leaving an aeromedical evacuation system. A Mobile Aeromedical Staging Facility (MASF) is used in tactical aeromedical evacuation. Although function is the same as any ASF, it is comprised of tentage, equi ...
(PowerPoint)
... CHA2DS2VASc = 0: n=6,919 person-years CHA2DS2VASc = 1: n=6,811 person-years CHA2DS2VASc = 2: n=3,347 person-years CHA2DS2VASc = 3: n=250 person-years ...
... CHA2DS2VASc = 0: n=6,919 person-years CHA2DS2VASc = 1: n=6,811 person-years CHA2DS2VASc = 2: n=3,347 person-years CHA2DS2VASc = 3: n=250 person-years ...
Pharmacy Law Review 2010
... dispensed only (i) upon a written prescription of a practitioner licensed by law to administer such drug, or (ii) upon an oral prescription of such practitioner which is reduced promptly to writing and filed by the pharmacist, or (iii) by refilling any such written or oral prescription if such refil ...
... dispensed only (i) upon a written prescription of a practitioner licensed by law to administer such drug, or (ii) upon an oral prescription of such practitioner which is reduced promptly to writing and filed by the pharmacist, or (iii) by refilling any such written or oral prescription if such refil ...
radiation therapy oncology group
... fractionation with split-course (AFX-S), and accelerated fractionation by concomitant boost (AFXCB) in the management of patients with stage III-IV HNSCC. Between September 1991 and August 1997, 1113 patients were enrolled. Analysis undertaken in September of 1999 revealed that AFX-CB (p=0.050) and ...
... fractionation with split-course (AFX-S), and accelerated fractionation by concomitant boost (AFXCB) in the management of patients with stage III-IV HNSCC. Between September 1991 and August 1997, 1113 patients were enrolled. Analysis undertaken in September of 1999 revealed that AFX-CB (p=0.050) and ...
Hospital-Acquired Pneumonia: Pathophysiology, Diagnosis, and
... are considered resistant to all beta-lactam agents.20 They additionally demonstrate a high rate of concomitant resistance to fluoroquinolones, making carbapenems the recommended first-line agents for ESBL-producing strains.19,20 P aeruginosa is the most common multidrug-resistant gram-negative bacil ...
... are considered resistant to all beta-lactam agents.20 They additionally demonstrate a high rate of concomitant resistance to fluoroquinolones, making carbapenems the recommended first-line agents for ESBL-producing strains.19,20 P aeruginosa is the most common multidrug-resistant gram-negative bacil ...
Individual patient treatment
... such as Drug and Therapeutics Committees or clinical effectiveness/evidence based practice committees. In-year requests will require previous priorities to be revisited with providers, if a new development or drug is felt to be of a greater priority than previously agreed plans. Drugs and technologi ...
... such as Drug and Therapeutics Committees or clinical effectiveness/evidence based practice committees. In-year requests will require previous priorities to be revisited with providers, if a new development or drug is felt to be of a greater priority than previously agreed plans. Drugs and technologi ...
May / June, 2011 - SKINmed Journal
... Dry skin of mild to moderate severity was the most frequently reported (≥ 1%) treatment related adverse event. Erythema, scaling, dryness, burning/stinging were also seen during treatment. DRUG INTERACTIONS Concomitant use of topical products with a strong drying effect can increase skin irritation. ...
... Dry skin of mild to moderate severity was the most frequently reported (≥ 1%) treatment related adverse event. Erythema, scaling, dryness, burning/stinging were also seen during treatment. DRUG INTERACTIONS Concomitant use of topical products with a strong drying effect can increase skin irritation. ...
DIAZEPAM Oral Solution 5 mg per 5 mL DIAZEPAM
... As with other agents which have anticonvulsant activity, when diazepam is used as an adjunct in treating convulsive disorders, the possibility of an increase in the frequency and/or severity of grand mal seizures may require an increase in the dosage of standard anticonvulsant medication. Abrupt wi ...
... As with other agents which have anticonvulsant activity, when diazepam is used as an adjunct in treating convulsive disorders, the possibility of an increase in the frequency and/or severity of grand mal seizures may require an increase in the dosage of standard anticonvulsant medication. Abrupt wi ...
Step 2 Clinical Skills (CS) Content Description and General Information
... differential diagnosis and a diagnostic work-up plan, as well as begin to develop an effective physicianpatient relationship. ...
... differential diagnosis and a diagnostic work-up plan, as well as begin to develop an effective physicianpatient relationship. ...
Suggestion from a pharmaceutical company
... Systematic review of stroke prevention in AF (2015) With the availability of 4 different NOACs as well as the VKAs, physicians now have a choice and can fit the drug to the patient. Various patient characteristics may influence the initial choice of one drug over another (Table 4). In the absence of ...
... Systematic review of stroke prevention in AF (2015) With the availability of 4 different NOACs as well as the VKAs, physicians now have a choice and can fit the drug to the patient. Various patient characteristics may influence the initial choice of one drug over another (Table 4). In the absence of ...
Alendrostad Veckotablett 70 mg tablet ENG SmPC
... attention if they develop symptoms of oesophageal irritation such as dysphagia, pain on swallowing, retrosternal pain or new/worsened heartburn. The risk of severe oesophageal side effects is thought to be greater in patients who do not take alendronate correctly and/or continue to take alendronate ...
... attention if they develop symptoms of oesophageal irritation such as dysphagia, pain on swallowing, retrosternal pain or new/worsened heartburn. The risk of severe oesophageal side effects is thought to be greater in patients who do not take alendronate correctly and/or continue to take alendronate ...
Linking evidence-based medicine to clinical decision analysis
... Objective: Evidence-based medicine (EBM) seeks to improve clinical practice by evaluating the quality of clinical evidence and ensuring that only the “best” evidence from clinical research is used in the management of individual patients. EBM has contributed to our understanding of the meaning of th ...
... Objective: Evidence-based medicine (EBM) seeks to improve clinical practice by evaluating the quality of clinical evidence and ensuring that only the “best” evidence from clinical research is used in the management of individual patients. EBM has contributed to our understanding of the meaning of th ...
2. qualitative and quantitative composition
... Polystyrene sulfonate (Kayexalate): Caution is advised when used concomitantly with polystyrene sulfonate (Kayexalate) due to the potential risks of reduced effectiveness of the resin in binding potassium, of metabolic alkalosis in patients with renal failure (reported with aluminium hydroxide and m ...
... Polystyrene sulfonate (Kayexalate): Caution is advised when used concomitantly with polystyrene sulfonate (Kayexalate) due to the potential risks of reduced effectiveness of the resin in binding potassium, of metabolic alkalosis in patients with renal failure (reported with aluminium hydroxide and m ...
Nutropin Prescribing Information
... recommended dosage at the start of treatment is not more than 0.006 mg/kg daily. The dose may be increased according to individual patient requirements to a maximum of 0.025 mg/kg daily in patients ≤ 35 years and to a maximum of 0.0125 mg/kg daily in patients over 35 years old. Clinical response, si ...
... recommended dosage at the start of treatment is not more than 0.006 mg/kg daily. The dose may be increased according to individual patient requirements to a maximum of 0.025 mg/kg daily in patients ≤ 35 years and to a maximum of 0.0125 mg/kg daily in patients over 35 years old. Clinical response, si ...
Addition of sildenafil to bosentan monotherapy in pulmonary arterial
... developed that target the prostacyclin (epoprostenol, treprostinil and iloprost), nitric oxide (sildenafil) or endothelin (bosentan) pathways. ...
... developed that target the prostacyclin (epoprostenol, treprostinil and iloprost), nitric oxide (sildenafil) or endothelin (bosentan) pathways. ...
OMT - American Osteopathic Association
... the rationale for treating this area, especially if the patient has no complaints related to this area. Treatment should be directed to the areas of documented somatic dysfunction and should not be aimed at areas unrelated to the diagnosis. The type, frequency and duration of OMT should be consisten ...
... the rationale for treating this area, especially if the patient has no complaints related to this area. Treatment should be directed to the areas of documented somatic dysfunction and should not be aimed at areas unrelated to the diagnosis. The type, frequency and duration of OMT should be consisten ...
How to select patients for atrial fibrillation ablation
... may decrease by 30% in patients with paroxysmal AF and improve in patients with chronic AF.4 Whether the improved transport function in patients with chronic AF and the residual transport function in patients with paroxysmal AF are sufficient to prevent left atrial thrombus formation is unclear. No ...
... may decrease by 30% in patients with paroxysmal AF and improve in patients with chronic AF.4 Whether the improved transport function in patients with chronic AF and the residual transport function in patients with paroxysmal AF are sufficient to prevent left atrial thrombus formation is unclear. No ...
Current drugs for weight loss
... medications are limited by side effects which result in high drop-out rates in medical trials as well as poor compliance in real world prescribing. In a population-based cohort, at one year after prescription of orlistat or sibutramine, less than 10% of patients were still on their medication and by ...
... medications are limited by side effects which result in high drop-out rates in medical trials as well as poor compliance in real world prescribing. In a population-based cohort, at one year after prescription of orlistat or sibutramine, less than 10% of patients were still on their medication and by ...
